KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) Other Non Operating Income (2017 - 2025)

LifeMD filings provide 6 years of Other Non Operating Income readings, the most recent being -$1.2 million for Q3 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A to -$1.2 million in Q3 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a N/A change, with the full-year FY2025 number at -$1.2 million, down 269.01% from a year prior.
  • Other Non Operating Income hit -$1.2 million in Q3 2025 for LifeMD, down from -$325198.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $184914.0 in Q1 2021 to a low of -$1.8 million in Q3 2021.
  • Median Other Non Operating Income over the past 4 years was -$901910.0 (2021), compared with a mean of -$759699.1.
  • Biggest five-year swings in Other Non Operating Income: tumbled 526.86% in 2021 and later skyrocketed 107.03% in 2022.
  • LifeMD's Other Non Operating Income stood at -$1.3 million in 2021, then surged by 104.82% to $63400.0 in 2022, then plummeted by 612.93% to -$325198.0 in 2023, then tumbled by 269.01% to -$1.2 million in 2025.
  • The last three reported values for Other Non Operating Income were -$1.2 million (Q3 2025), -$325198.0 (Q1 2023), and $63400.0 (Q2 2022) per Business Quant data.